AI-generated summary
This review describes dermocosmetic approaches for hyperpigmentation such as lentigo and melasma, which the authors describe as benign conditions. They report that depigmenting products combine turnover activators, exfoliants, melanogenesis-targeting ingredients and antioxidants without hydroquinone's side effects, and that sun protection is essential. The authors state that efficacy depends on the specific etiology and that treatment should be tailored case by case.
- Who or what was studied
- Individuals with hyperpigmentation, including lentigo and melasma
- Limits stated in the abstract
- The abstract gives no included study count, quantitative efficacy data or certainty assessment, and efficacy is described as etiology-dependent.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.